Table 2. | Patient background |
| Placebo gargle | Rebamipide gargle | P | ||
| Sex (Male/Female) | 7/5 | 7/5 | ||
|
Age (years) |
31-40 | 0 | 2 | χ2 = 6.8; df = 5; P = 0.238b |
| 41-50 | 0 | 2 | ||
| 51-60 | 5 | 5 | ||
| 61-70 | 2 | 2 | ||
| 71-80 | 4 | 1 | ||
| 81-90 | 1 | 0 | ||
| Mean age (SD) | 65.9 (10.8) | 54.9 (11.5) | 0.077b | |
| Primary site of cancer | ||||
| Maxillary gingiva | 3 | 2 | χ2 = 3.7; df = 4; P = 0.522b |
|
| Mandibular gingiva | 4 | 3 | ||
| Tongue | 2 | 6 | ||
| Oral floor | 2 | 1 | ||
| Buccal mucosa | 1 | 0 | ||
| Initial/relapse | 11/1 | 11/1 | ||
| Stage of cancer | ||||
| Stage I | 0 | 4 | χ2 = 6.0; df = 3; P = 0.125b |
|
| Stage II | 4 | 4 | ||
| Stage III | 1 | 1 | ||
| Stage IV | 6 | 2 | ||
| T size of cancer | ||||
| T1 | 0 | 4 | χ2 = 7.2; df = 3; P = 0.065b |
|
| T2 | 5 | 5 | ||
| T3 | 3 | 2 | ||
| T4 | 3 | 0 | ||
|
WBCa count at baseline, mean (SD) |
6.56 (1.83) | 5.80 (2.15) | 0.34b | |
|
Neutrophila count at baseline, mean (SD) |
3.94 (1.37) | 3.61 (2.15) | 0.48b | |
a×103 cells/mm3.
|
.png)
.png)
.png)